Novartis

Novartis

Senior Imaging Expert (Dual Level Posting)

Cambridge (USA) · Senior

Sponsorship not specifiedDetected 72 days ago
Machine LearningData AnalysisStakeholder ManagementClinical TrialsClinical ResearchPatient CareResearchLeadershipCommunicationCollaborationProblem SolvingMentoring

Stay score

odds of building a lasting career here

40Risky
Cap-exempt (no lottery)0
Sponsors this role90
Entry-level history0
PERM / green-card track0
Lottery odds40
Fits your clock70

Thin sponsorship signal and lottery-bound. A low-probability bet with your clock running. Prioritize cap-exempt roles and proven entry-level sponsors first.

Lottery odds assume a STEM candidate.

Personalize to your clock →

Employer immigration record

from this employer's Department of Labor filings

Files H-1B transfers

1 transfer filing in the last year, covering 1 worker. Median labor-condition decision: 7 days. An employer that already files transfers is one that can take over an existing H-1B.

Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • Act as an internal expert in molecular and clinical imaging, including PET, SPECT and other advanced imaging methodologies relevant to clinical and translational drug development.
  • Senior Principal Scientist or Associate Director
  • Be part of an imaging department with deep expertise in structural, molecular, and quantitative biomarkers and their application in translation and development.

Responsibilities

  • You will partner with clinical trial teams to establish the role of imaging endpoints along novel biological mechanisms across diverse therapeutic areas.
  • Partner with Oncology and General Medicine teams to develop and lead fit-for-purpose imaging strategies across research, early development and late-stage clinical development.
  • Develop imaging biomarker, target engagement and translational imaging strategies that generate decision-critical evidence for patient selection, pharmacodynamics, efficacy, safety and mechanism of action.
  • Collaborate with internal operational teams, imaging CROs, academic centers and external experts to design, execute and interpret imaging readouts across multisite clinical trials.
  • Ensure quality and timely execution of imaging trials to deliver critical drug development decisions
  • We strive to create an inclusive workplace that cultivates bold innovation through collaboration and empowers our people to unleash their full potential.

Requirements

  • PhD or MD or MD/PhD with 8+ years of experience in PET/SPECT Imaging in academia or industry, including at least 5 years supporting clinical drug development.
  • Deep technical expertise in PET and/or SPECT as applied to clinical drug development
  • Demonstrated track record of innovative research preferably across imaging modalities
  • Strong communication skills in English, with demonstrated ability to influence, mentor and act as a collaborative servant leader.
  • The final level & title of the offer role would be determined by the hiring team based on the skills, experience & capabilities required to perform the role at the level the role has been offered.

Nice to have

  • Experience with PET/SPECT tracer development, radioligand imaging, dosimetry, receptor occupancy or clinical Radioligand/Radiopharmaceutical Therapy (RLT/RPT) is a plus.
  • Experience in regulatory interactions, submissions, first-in-human imaging studies, endpoint validation or qualification is a plus.
  • Understanding of sites, budgets, imaging CROs, imaging data standards and experience with multisite trial execution is a plus.
  • Strong understanding of clinical trial design, endpoint development, biomarker strategy, statistical considerations and clinical data flow is required.
  • Experience with clinical protocol writing across line functions is required.

Compensation

  • $132,300 and $245,700 per year.
  • $145,600 and $270,400 per year.
  • The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically.
  • Novartis may change the published salary range based on company and market factors.
  • Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.
  • $132,300.00 - $245,700.00

Benefits

  • US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits.
  • In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.
  • To learn more about the culture, rewards and benefits we offer our people click here.

Company info

  • As a part of building imaging endpoints, the role also provides unique exposure to variety of other critical biomarkers (soluble and genetics) for an integrated view of identifying unique patient populations, assess target engagement and generate decision-critical readouts of efficacy, safety and mechanism of action.

Equal opportunity

  • The Novartis Group of Companies are Equal Opportunity Employers.
  • The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities.
Apply directly at Novartis →Create a free account for alerts like thisView Novartis immigration profile

This listing is sourced directly from Novartis's careers page and normalized into a canonical job model.